PCI-24781
CAS No. 783355-60-2
PCI-24781 ( CRA 024781;CRA 24781;PCI 24781;Abexinostat )
产品货号. M15956 CAS No. 783355-60-2
A broad spectrum HDAC inhibitor; inhibits pure recombinant HDAC1 with Ki of 7 nM.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥373 | 有现货 |
|
5MG | ¥583 | 有现货 |
|
10MG | ¥891 | 有现货 |
|
25MG | ¥1539 | 有现货 |
|
50MG | ¥2778 | 有现货 |
|
100MG | ¥4366 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称PCI-24781
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述A broad spectrum HDAC inhibitor; inhibits pure recombinant HDAC1 with Ki of 7 nM.
-
产品描述A broad spectrum HDAC inhibitor; inhibits pure recombinant HDAC1 with Ki of 7 nM; also inhibits HDAC2, HDAC3/SMRT, HDAC6, HDAC8, and HDAC10 in the nanomolar range; causes the accumulation of acetylated histone and acetylated tubulin in tumor cell lines; decreases RAD51 expression and inhibits homologous recombination.Blood Cancer Phase 2 Clinical
-
同义词CRA 024781;CRA 24781;PCI 24781;Abexinostat
-
通路Cell Cycle/DNA Damage
-
靶点HDAC
-
受体HDAC1;HDAC10;HDAC2;HDAC3/SMRT;HDAC6
-
研究领域Cancer
-
适应症Blood cancer
化学信息
-
CAS Number783355-60-2
-
分子量397.42
-
分子式C21H23N3O5
-
纯度>98% (HPLC)
-
溶解度10 mM in DMSO
-
SMILESO=C(C(O1)=C(CN(C)C)C2=C1C=CC=C2)NCCOC3=CC=C(C(NO)=O)C=C3
-
化学全称2-Benzofurancarboxamide, 3-[(dimethylamino)methyl]-N-[2-[4-[(hydroxyamino)carbonyl]phenoxy]ethyl]-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
2. Adimoolam S, et al. Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19482-7.
3. Salvador MA, et al. Clin Cancer Res. 2013 Dec 1;19(23):6520-31.
产品手册
关联产品
-
4SC-202 free base
4SC-202 is a selective class I HDAC inhibitor with IC50 of 1.20 μM, 1.12 μM, and 0.57 μM for HDAC1, HDAC2, and HDAC3, respectively.
-
2-hexyl-4-Pentynoic ...
2-hexyl-4-Pentynoic Acid, a valproic acid (VPA) derivatives, is a potent and robust HDACs inhibitor with IC50 value of 13 μM.
-
Vorinostat
A potent HDAC inhibitor, inhibits the activities of HDAC1 and HDAC3 with IC50 of 10 nM and 20 nM, respectively.